title: Trends and present treatment patterns of early breast cancer in Southwest China.
abstract: To analyze the changing patterns of treatment and to explore the current treatment approaches for breast cancer in Southwest China, we conducted a population-based retrospective cohort study of early breast cancer cases. The data of patients who registered in the information management system for breast cancer in Huaxi Hospital, Sichuan University from 1989 to 2012 were extracted. Nearly all patients underwent surgery, among whom radical mastectomy was the predominant option. Chemotherapy (88.7%) was the most predominant adjuvant therapy approach. The percentage of patients receiving radiation therapy displayed fluctuant increase, which was 37.1 % in 2001 and reached up to 67.6% in 2011. Besides, the endocrinetherapy became more and more popular in the hormone-receptor positive patients and the percentage of endocrinetherapy was increased from 54.1 at 2001 to 85.6% at 2011. However, more than 10% of hormone-receptor positive patients still did not receive endocrinetherapy annually. The hormone-receptor positive patients who received endocrinetherapy had better 5-year disease free survival (DFS) and overall survival (OS) compared to those without endocrinetherapy (5-y DFS: 88.4% vs. 75.1 %, P < 0.001; 5-y OS: 95.7% vs. 88.4%, P < 0.001). N stage appeared to have greater impact on the 5-year DFS and OS than molecular subtyping. The treatment for breast cancer in China has been significantly improved but more attentions should be paid to radiotherapy and endocrine therapy. In addition, the value of N stage in the prognosis of breast cancer should not be ignored when the molecular typing draws more and more attentions.
authors.affiliation: Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, No.37 Guo Xue Xiang, Chengdu, 610041, China.
authors.forename: Qiancheng
authors.initials: Q
authors.lastname: Hu
authors.forename: Ting
authors.initials: T
authors.lastname: Luo
authors.forename: Ping
authors.initials: P
authors.lastname: He
authors.forename: Xiaorong
authors.initials: X
authors.lastname: Zhong
authors.forename: Tinglun
authors.initials: T
authors.lastname: Tian
authors.forename: Qing
authors.initials: Q
authors.lastname: Lv
authors.forename: Xi
authors.initials: X
authors.lastname: Yan
authors.forename: Hong
authors.initials: H
authors.lastname: Zheng
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D044466:Asian People; D001943:Breast Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D018567:Breast Neoplasms, Male / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*; D002681:China / Q000453:epidemiology; D015331:Cohort Studies; D004358:Drug Therapy / Q000706:statistics & numerical data / Q000639:trends; D005260:Female; D006801:Humans; D008297:Male; D008408:Mastectomy / Q000706:statistics & numerical data / Q000639:trends; D008875:Middle Aged; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data* / Q000639:trends*; D011878:Radiotherapy / Q000706:statistics & numerical data / Q000639:trends; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult
references.citation: Ann Oncol. 2005 Oct;16(10):1569-83
references.pmid: 16148022
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6598-607
references.pmid: 16166438
references.citation: Breast Cancer Res Treat. 2013 Jan;137(2):465-70
references.pmid: 23224235
references.citation: Cancer. 2007 May 1;109(9):1721-8
references.pmid: 17387718
references.citation: Breast Cancer Res Treat. 2011 Apr;126(2):529-37
references.pmid: 20803066
references.citation: Ann Oncol. 2011 Aug;22(8):1736-47
references.pmid: 21709140
references.citation: J Clin Oncol. 2001 Sep 15;19(18):3808-16
references.pmid: 11559718
references.citation: N Engl J Med. 2005 Dec 29;353(26):2747-57
references.pmid: 16382061
references.citation: Asian Pac J Cancer Prev. 2004 Oct-Dec;5(4):419-27
references.pmid: 15546249
references.citation: Indian J Med Res. 2010 Sep;132:287-94
references.pmid: 20847375
references.citation: J Clin Oncol. 2003 Sep 1;21(17):3357-65
references.pmid: 12847142
references.citation: Cancer Sci. 2012 Sep;103(9):1679-87
references.pmid: 22625227
references.citation: Lancet. 2002 Jun 22;359(9324):2131-9
references.pmid: 12090977
references.citation: Lancet. 2005 May 14-20;365(9472):1687-717
references.pmid: 15894097
references.citation: Eur J Cancer. 2004 Dec;40(18):2742-7
references.pmid: 15571956
references.citation: Mol Med Rep. 2012 Oct;6(4):779-82
references.pmid: 22797840
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: J Surg Res. 2007 Nov;143(1):109-18
references.pmid: 17950079
references.citation: N Engl J Med. 2002 Oct 17;347(16):1233-41
references.pmid: 12393820
references.citation: Breast Cancer Res Treat. 2009 Sep;117(2):409-16
references.pmid: 19153831
references.citation: N Engl J Med. 2004 Mar 11;350(11):1081-92
references.pmid: 15014181
references.citation: Arch Pathol Lab Med. 2010 Jul;134(7):e48-72
references.pmid: 20586616
references.citation: J Clin Oncol. 2006 Dec 20;24(36):5652-7
references.pmid: 17116942
references.citation: Breast. 2007 Dec;16 Suppl 2:S72-7
references.pmid: 17714947
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907
references.pmid: 20647400
references.citation: J Am Coll Surg. 2009 Oct;209(4):425-433.e2
references.pmid: 19801315
references.citation: Lancet. 2005 Jan 1-7;365(9453):60-2
references.pmid: 15639680
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references.pmid: 11553815
references.citation: J Surg Oncol. 2009 Aug 1;100(2):89-94
references.pmid: 19544363
references.citation: BMC Cancer. 2011 Aug 22;11:364
references.pmid: 21859480
references.citation: Cancer. 2007 Mar 1;109(5):832-9
references.pmid: 17243168
references.citation: Cancer. 2014 Mar 1;120(5):642-51
references.pmid: 24222194
references.citation: J Natl Cancer Inst. 1995 Oct 4;87(19):1441-5
references.pmid: 7674331
references.citation: J Clin Oncol. 2001 Sep 15;19(18):3817-27
references.pmid: 11559719
references.citation: Ann Oncol. 2009 Aug;20(8):1319-29
references.pmid: 19535820
references.citation: Breast J. 2006 Jan-Feb;12 Suppl 1:S70-80
references.pmid: 16430400
references.citation: J Natl Cancer Inst. 1998 Nov 4;90(21):1601-8
references.pmid: 9811309
references.citation: Oncologist. 2011;16(8):1101-10
references.pmid: 21680575
references.citation: J Clin Oncol. 2011 Sep 1;29(25):3366-73
references.pmid: 21768458
references.citation: N Engl J Med. 2005 Oct 27;353(17):1784-92
references.pmid: 16251534
references.citation: JAMA. 2006 Jun 7;295(21):2492-502
references.pmid: 16757721
references.citation: N Engl J Med. 2011 Oct 6;365(14):1273-83
references.pmid: 21991949